Get started
Author

Bogdan A. Zagribelnyy

Observed names: B. A. Zagribelnyy, B. Zagribelnyy, Bogdan Zagribelny, Bogdan Zagribelnyy, Zagribelny, Bogdan, Zagribelnyy, Bogdan, Zagribelnyy, Bogdan A., Б.А. Загрибельный
Observed institutions: Moscow Institute of Physics and Technology, Lomonosov Moscow State University, ChemDiv (United States), Merck (Singapore), Insilico Medicine (United States), 3D Medicines, Inc. (China)
ORCID: 0000-0003-3799-2720
Observed ORCID: 0000-0003-3799-2720
OpenAlex ID: A5036803601
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
2019 · Alex Zhavoronkov, Yan A. Ivanenkov, et al. · Nature Biotechnology · 1,701
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
2023 · Yan A. Ivanenkov, Daniil Polykovskiy, et al. · Journal of Chemical Information and Modeling · 249
PDF
Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?
2019 · Yan A. Ivanenkov, Bogdan A. Zagribelnyy, et al. · Journal of Medicinal Chemistry · 126
Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches
2020 · Alex Zhavoronkov, Vladimir Aladinskiy, et al. · ChemRxiv · 89
Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches
2020 · Alex Zhavoronkov, Vladimir Aladinskiy, et al. · ChemRxiv · 73
PDF
The Hitchhiker’s Guide to Deep Learning Driven Generative Chemistry
2023 · Yan Ivanenkov, Bogdan Zagribelnyy, et al. · ACS Medicinal Chemistry Letters · 58
PDF
Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality
2020 · Alex Zhavoronkov, Bogdan Zagribelnyy, et al. · ChemRxiv · 47
PDF
Identification of Novel Antibacterials Using Machine Learning Techniques
2019 · Yan A. Ivanenkov, Alex Zhavoronkov, et al. · Frontiers in Pharmacology · 47
PDF
A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
2025 · Jing Sun, Deheng Sun, et al. · Nature Communications · 41
PDF
Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality
2020 · Alex Zhavoronkov, Bogdan Zagribelnyy, et al. · ChemRxiv · 29
Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53–MDM2 Protein–Protein Interaction
2020 · Anastasia Beloglazkina, Alexander Barashkin, et al. · Chemistry of Heterocyclic Compounds · 27
Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission
2022 · Jeremy C. Jones, Bogdan Zagribelnyy, et al. · PLoS Pathogens · 20
PDF
Chemistry42: An AI-based platform for de novo molecular design
2021 · Ivanenkov, Yan A., Zhebrak, Alex, et al. · arXiv (Cornell University) · 13
PDF
When Single Answer Is Not Enough: Rethinking Single-Step Retrosynthesis Benchmarks for LLMs
2026 · Zagribelnyy, Bogdan, Ilin, Ivan, et al. · arXiv (Cornell University) · 8
PDF
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2
2022 · Andrey A. Ivashchenko, Bogdan A. Zagribelnyy, et al. · Molecules · 5
PDF
Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an in vitro study
2024 · Sergei Evteev, Yan Ivanenkov, et al. · Frontiers in Chemistry · 4
Molecular LEGION: incalculably large coverage of chemical space around the NLRP3 target
2026 · Bogdan Zagribelnyy, Vladimir Aladinskiy, et al. · Scientific Data · 3
PDF
AlphaFold for a medicinal chemist: tool or toy?
2024 · Ya. A. Ivanenkov, S. A. Evteev, et al. · Russian Chemical Reviews · 3
PDF
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors
2020 · Andrey A. Ivashchenko, Yan A. Ivanenkov, et al. · Bioorganic & Medicinal Chemistry · 3
Training Chemical Plausibility-Aware Large Language Models for Single-Step Retrosynthesis
2026 · Zagribelnyy, Bogdan, Ilin, Ivan, et al. · arXiv (Cornell University) · 2
PDF
MMAI Gym for Science: Training Liquid Foundation Models for Drug Discovery
2026 · Maksim Kuznetsov, Zulfat Miftahutdinov, et al. · Conference on Empirical Methods in Natural Language Processing (EMNLP) · 1
PDF
Large-scale High-throughput Screening Revealed 5'-(carbonylamino)-2,3'- bithiophene-4'-carboxylate as Novel Template for Antibacterial Agents
2019 · Yan A. Ivanenkov, Renat S. Yamidanov, et al. · Current Drug Discovery Technologies · 1
A novel, covalent and highly synthetically accessible SARS-CoV-2 Mpro chloroacetamide inhibitor
2025 · B. Zagribelnyy, A. Zhavoronkov · Worldwide Protein Data Bank
Molecular LEGION: Latent Enumeration, Generation, Integration, Optimization and Navigation. A case study of incalculably large chemical space coverage around the NLRP3 target
2025 · Bogdan Zagribelnyy, Vladimir Aladinskiy, et al. · ChemRxiv
PDF
Modeling of synthetic accessibility of potential drug molecules containing five-membered aromatic heterocycles
2025 · N. Bondarev, B. Zagribelnyy, et al. · Russian Chemical Bulletin
Works count: 29
Citation count: 2,664
H-index: 13
I10-index: 14
Year
Topic
Type